Literature DB >> 9836472

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

J M Lancaster1, M E Carney, J Gray, J Myring, C Gumbs, J Sampson, D Wheeler, E France, R Wiseman, P Harper, P A Futreal.   

Abstract

Mutations in the BRCA1/BRCA2 genes account for varying proportions of breast cancer families studied, and demonstrate considerable variation in mutational spectra coincident with ethnic and geographical diversity. We have screened for mutations in 17 families from Wales with two or more cases of breast cancer under age 50 and/or ovarian cancer. Eight out of 17 (47%) families had demonstrable mutations. Six out of 17 (35%) carried BRCA1 mutations and 2 out of 17 (12%) carried BRCA2 mutations. Two recurrent mutations in BRCA1 were identified, which appear to represent founder mutations in this population. These data support the existence of additional breast and ovarian cancer susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836472      PMCID: PMC2063207          DOI: 10.1038/bjc.1998.701

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales.

Authors:  J P Cheadle; M C Goodchild; A L Meredith
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

3.  Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles.

Authors:  G Lucotte; S Hazout
Journal:  Hum Biol       Date:  1995-08       Impact factor: 0.553

4.  Dideoxy fingerprinting assay for BRCA1 mutation analysis.

Authors:  J M Lancaster; A Berchuck; P A Futreal; R W Wiseman
Journal:  Mol Carcinog       Date:  1997-07       Impact factor: 4.784

5.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

6.  Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Authors:  S Håkansson; O Johannsson; U Johansson; G Sellberg; N Loman; A M Gerdes; E Holmberg; N Dahl; N Pandis; U Kristoffersson; H Olsson; A Borg
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

7.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Authors:  S Neuhausen; T Gilewski; L Norton; T Tran; P McGuire; J Swensen; H Hampel; P Borgen; K Brown; M Skolnick; D Shattuck-Eidens; S Jhanwar; D Goldgar; K Offit
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  BRCA1 polymorphisms.

Authors:  I G Campbell; R Schroff; P Englefield; D M Eccles
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Authors:  L H Castilla; F J Couch; M R Erdos; K F Hoskins; K Calzone; J E Garber; J Boyd; M B Lubin; M L Deshano; L C Brody
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

10.  An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Authors:  S A Narod; D Ford; P Devilee; R B Barkardottir; H T Lynch; S A Smith; B A Ponder; B L Weber; J E Garber; J M Birch
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

View more
  5 in total

1.  BRCA2 T2722R is a deleterious allele that causes exon skipping.

Authors:  James D Fackenthal; Luca Cartegni; Adrian R Krainer; Olufunmilayo I Olopade
Journal:  Am J Hum Genet       Date:  2002-07-19       Impact factor: 11.025

2.  BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.

Authors:  J T Bergthorsson; B Ejlertsen; J H Olsen; A Borg; K V Nielsen; R B Barkardottir; S Klausen; H T Mouridsen; K Winther; K Fenger; A Niebuhr; T L Harboe; E Niebuhr
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

3.  BRCA1 and BRCA2 mutations in Scotland and Northern Ireland.

Authors: 
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

4.  Evidence of a founder BRCA1 mutation in Scotland.

Authors:  A Liede; B Cohen; D M Black; R H Davidson; A Renwick; E Hoodfar; O I Olopade; M Micek; V Anderson; R De Mey; A Fordyce; E Warner; J L Dann; M C King; B Weber; S A Narod; C M Steel
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

Review 5.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.